Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Biologic response of menopausal women to 17B-estradiol

Next Previous
X
Search
Trial Profile

Biologic response of menopausal women to 17B-estradiol

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jan 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol acetate (Primary) ; Progesterone
  • Indications Atrophic vaginitis; Menopausal syndrome; Vasomotor symptoms
  • Focus Pharmacodynamics
  • Acronyms ELITE

    • Most Recent Events

    • 01 Dec 2021 Results of a post hoc sub-analysis assessing the effect of oral E2 plus vaginal P4 on endometrial thickness, endometrial biopsy results, cervical cytology and overall cancer incidence among healthy postmenopausal women during the ELITE follow-up published in the Maturitas
    • 03 Oct 2020 Results presented at the North American Menopause Society 2020 Annual Meeting
    • 10 Sep 2020 Results (n=275) of post hoc analysis evaluating factors associated with serum estradiol levels among healthy postmenopausal women using hormone therapy, published in the Obstetrics and Gynecology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top